Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
How has the ectopic pregnancy grown historically, and what trends indicate future expansion?
The ectopic pregnancy market size has grown strongly in recent years. It will grow from $8.09 billion in 2024 to $8.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased awareness and early detection, rise in the incidence of pelvic inflammatory disease, expansion in research and development in women's reproductive health, increased awareness and education about ectopic pregnancies, increased fertility treatments, enhanced maternal healthcare infrastructure, and enhanced maternal healthcare infrastructure.
The ectopic pregnancy market size is expected to see strong growth in the next few years. It will grow to $10.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing prevalence of gynecological disorders, rising awareness and early detection, growing healthcare expenditure, rising incidence rates, increasing healthcare services, and growing adoption of minimally invasive surgeries. Major trends in the forecast period include the adoption of advanced diagnostic tools, advancement in minimally invasive surgical procedures, advancement in treatment options, advancements in early diagnostic technologies, and expansion of telemedicine for remote patient monitoring.
Download Your Free Sample PDF:
Which key factors are driving the expansion of the ectopic pregnancy industry?
The increase in the use of contraceptive devices is expected to propel the growth of the ectopic pregnancy market going forward. Contraceptive devices are tools used to prevent pregnancy by inhibiting the fertilization of an egg or the implantation of a fertilized egg. The use of contraceptive devices is increasing due to a growing emphasis on family planning, population control, and the desire to prevent unintended pregnancies. The increasing use of contraceptive devices, particularly intrauterine devices (IUDs), can elevate the risk of ectopic pregnancy if pregnancy occurs, as these devices can alter the normal movement of the egg through the fallopian tubes, leading to implantation outside the uterus. For instance, in February 2024, according to the Faculty of Sexual and Reproductive Healthcare (FSRH), a UK-based organization for family planning and sexual health, from 2022 to 2023, the utilization of long-acting reversible contraceptives (LARC) rose to 44.1 per 1,000 people, up from 41.8 per 1,000 in the preceding year, 2021 to 2022. Therefore, the increase in the use of contraceptive devices is driving the growth of the ectopic pregnancy market.
How is the ectopic pregnancy market segmented by product, application, and end-user?
The ectopic pregnancy market covered in this report is segmented –
1) By Type: Tubal Ectopic Pregnancy, Non-Tubal Ectopic Pregnancy, Heterotopic Ectopic Pregnancy, Other Types
2) By Treatment: Folic Acid Analogue, Corticosteroid, Other Treatments
3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, Other Distribution Channels
4) By End-User: Hospitals, Clinics, Fertility Centers, Other End-Users
Subsegments:
1) By Tubal Ectopic Pregnancy: Ampullary Ectopic Pregnancy, Isthmic Ectopic Pregnancy, Fimbrial Ectopic Pregnancy, Interstitial Ectopic Pregnancy
2) By Non-Tubal Ectopic Pregnancy: Ovarian Ectopic Pregnancy, Cervical Ectopic Pregnancy, Abdominal Ectopic Pregnancy, Caesarean Scar Ectopic Pregnancy
3) By Heterotopic Ectopic Pregnancy: Single Gestation With Ectopic Pregnancy, Multiple Gestation With Ectopic Pregnancy
4) By Other Types: Cornual Ectopic Pregnancy, Rudimentary Horn Pregnancy
View The Full Market Report:
What are the key trends shaping the ectopic pregnancy market in the forecast period?
Major companies operating in the ectopic pregnancy market are developing artificial intelligence (AI)-powered ultrasound systems to enhance diagnostic accuracy and improve patient outcomes. AI-powered ultrasound systems use machine learning algorithms to analyze ultrasound images, enhancing the accuracy and speed of ectopic pregnancy diagnosis. For instance, in April 2024, GE HealthCare, a US-based medical technology and diagnostics company, launched the Voluson Signature 20 and 18 ultrasound systems, featuring a complete integration of artificial intelligence (AI), enhanced tools, and an ergonomic design to reduce exam duration for clinicians while providing clearer insights into women's health conditions. These advanced systems merge high-performance hardware with adaptable, scalable software, aimed at boosting clinicians' confidence in their diagnostic and treatment decisions.
Which leading companies are dominating the ectopic pregnancy market landscape?
Major companies operating in the ectopic pregnancy market are Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Fresenius Kabi USA, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, H. Lundbeck A/S, Dr. Reddy's Laboratories, Hikma Pharmaceuticals Plc, Lupin Pharmaceuticals Inc., Zydus Pharmaceuticals, Stason Pharmaceuticals, Actiza Pharmaceutical Private Limited, Zhejiang Davi Pharmaceutical Co., Ltd.
Which geographic areas are expected to offer the highest growth opportunities in theectopic pregnancy market?
North America was the largest region in the ectopic pregnancy market in 2023. The regions covered in the ectopic pregnancy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Ectopic Pregnancy Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Ectopic Pregnancy Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment